M

MaxCyte Inc
NASDAQ:MXCT

Watchlist Manager
MaxCyte Inc
NASDAQ:MXCT
Watchlist
Price: 3.55 USD 0.28% Market Closed
Market Cap: 373.8m USD
Have any thoughts about
MaxCyte Inc?
Write Note

MaxCyte Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MaxCyte Inc
Net Income (Common) Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
M
MaxCyte Inc
NASDAQ:MXCT
Net Income (Common)
-$37.9m
CAGR 3-Years
-47%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Net Income (Common)
$6.1B
CAGR 3-Years
-11%
CAGR 5-Years
11%
CAGR 10-Years
14%
Danaher Corp
NYSE:DHR
Net Income (Common)
$3.9B
CAGR 3-Years
-12%
CAGR 5-Years
10%
CAGR 10-Years
4%
Mettler-Toledo International Inc
NYSE:MTD
Net Income (Common)
$785.7m
CAGR 3-Years
3%
CAGR 5-Years
8%
CAGR 10-Years
10%
Agilent Technologies Inc
NYSE:A
Net Income (Common)
$1.4B
CAGR 3-Years
13%
CAGR 5-Years
6%
CAGR 10-Years
7%
IQVIA Holdings Inc
NYSE:IQV
Net Income (Common)
$1.4B
CAGR 3-Years
22%
CAGR 5-Years
42%
CAGR 10-Years
15%

See Also

What is MaxCyte Inc's Net Income (Common)?
Net Income (Common)
-37.9m USD

Based on the financial report for Dec 31, 2023, MaxCyte Inc's Net Income (Common) amounts to -37.9m USD.

What is MaxCyte Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-34%

Over the last year, the Net Income (Common) growth was -61%. The average annual Net Income (Common) growth rates for MaxCyte Inc have been -47% over the past three years , -34% over the past five years .

Back to Top